Orlaam, also known by its generic name levomethadyl acetate, is a medication that was previously used in the treatment of opioid dependence. It belongs to the class of drugs known as opioid agonists, which means it binds to opioid receptors in the brain and produces similar effects to opioids.
Orlaam was primarily used as a maintenance treatment for individuals with opioid dependence, providing long-lasting effects and reducing the craving for opioids. It worked by blocking the euphoric effects of opioids and helping to suppress withdrawal symptoms. Orlaam was typically administered orally under medical supervision.
However, it is important to note that Orlaam is no longer available in many countries, including the United States. In 2003, the U.S. Food and Drug Administration (FDA) requested the manufacturer to cease production due to concerns about potentially serious cardiac side effects associated with the medication.
If you or someone you know is struggling with opioid dependence, it is recommended to seek help from healthcare professionals or addiction specialists who can provide appropriate guidance and support. There are other medications and treatment options available for opioid dependence, such as methadone and buprenorphine, which have demonstrated effectiveness in reducing opioid cravings and supporting recovery.
It is crucial to consult with a healthcare professional to discuss the most suitable treatment options based on individual needs and circumstances. They can assess your situation and guide you towards the most appropriate course of action for managing opioid dependence.